BIOLIT ApS: Financial statements 2020
CVR: 10068460
BIOLIT ApS (CVR 10068460) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,529,689 and a net result of DKK 1,736,745 compared with DKK 1,475,787 the year before. That is a decrease of 22.2% compared with the year before. Equity amounted to DKK 8,818,653. The solvency ratio was 59.3%.
- Gross Profit
- 1,529,689 kr.
- Profit/Loss
- 1,736,745 kr.
- Equity
- 8,818,653 kr.
- Total Assets
- 14,880,522 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.5 mio. | 1.7 mio. | 8.8 mio. | - |
| 2019 | - | 2 mio. | 1.5 mio. | 7.1 mio. | - |
| 2018 | - | 1.3 mio. | 954 t. | 5.6 mio. | - |
| 2017 | - | 1.4 mio. | 1.1 mio. | 4.7 mio. | - |
| 2016 | - | 1.8 mio. | 1.4 mio. | 3.6 mio. | - |
How creditworthy is BIOLIT ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BIOLIT ApS
BIOLIT ApS is a Danish company of the type Anpartsselskab based in Fredensborg, founded in 2001. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Flemming Velin. The company is owned by SCANVET ANIMAL HEALTH A/S. The company has 3 employees. In 2025, the company reported a gross profit of DKK 125,902 and a net result of DKK -20,616,619 compared with DKK 13,041,006 the year before. Equity amounted to DKK 10,762,624.
